Microarray analysis has revolutionized the role of genomic prognostication in breast cancer. However, most studies are single series studies, and suffer from methodological problems. We sought to use a meta-analytic approach in combining multiple publicly available datasets, while correcting for batch effects, to reach a more robust oncogenomic analysis.The aim of the present study was to find gene sets associated with distant metastasis free survival (DMFS) in systemically untreated, node-negative breast cancer patients, from publicly available genomic microarray datasets.Four microarray series (having 742 patients) were selected after a systematic search and combined. Cox regression for each gene was done for the combined dataset (univari...
Multiple studies have illustrated that gene expression profiling of primary breast cancers throughou...
Triple-negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer that lacks the ...
Background: Gene expression measurements from breast cancer (BrCa) tumors are established clinical p...
Microarray analysis has revolutionized the role of genomic prognostication in breast cancer. However...
<div><p>Introduction</p><p>Microarray analysis has revolutionized the role of genomic prognosticatio...
Abstract Background Metastasis is believed to progress in several steps including different pathways...
BackgroundBreast cancer metastasis is a highly prevalent cause of death for European females. DNA mi...
BACKGROUND: Different microarray studies have compiled gene lists for predicting outcomes of a range...
Abstract Background There is an urgent need for new prognostic markers of breast cancer metastases t...
The transcriptome of breast cancers have been extensively screened with microarrays and large sets o...
Introduction Breast cancer subtyping and prognosis have been studied extensively by gene expression ...
The development of signature biomarkers has gained considerable attention in the past decade. Althou...
<p>A) Distant metastasis-free survival analysis of the DMFS gene signatures (left panels) or the met...
Breast cancer is the most frequent neoplasm and the leading cause of cancer mortality in women world...
textabstractPurpose: We previously discovered an extracellular matrix (ECM) gene cluster associated ...
Multiple studies have illustrated that gene expression profiling of primary breast cancers throughou...
Triple-negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer that lacks the ...
Background: Gene expression measurements from breast cancer (BrCa) tumors are established clinical p...
Microarray analysis has revolutionized the role of genomic prognostication in breast cancer. However...
<div><p>Introduction</p><p>Microarray analysis has revolutionized the role of genomic prognosticatio...
Abstract Background Metastasis is believed to progress in several steps including different pathways...
BackgroundBreast cancer metastasis is a highly prevalent cause of death for European females. DNA mi...
BACKGROUND: Different microarray studies have compiled gene lists for predicting outcomes of a range...
Abstract Background There is an urgent need for new prognostic markers of breast cancer metastases t...
The transcriptome of breast cancers have been extensively screened with microarrays and large sets o...
Introduction Breast cancer subtyping and prognosis have been studied extensively by gene expression ...
The development of signature biomarkers has gained considerable attention in the past decade. Althou...
<p>A) Distant metastasis-free survival analysis of the DMFS gene signatures (left panels) or the met...
Breast cancer is the most frequent neoplasm and the leading cause of cancer mortality in women world...
textabstractPurpose: We previously discovered an extracellular matrix (ECM) gene cluster associated ...
Multiple studies have illustrated that gene expression profiling of primary breast cancers throughou...
Triple-negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer that lacks the ...
Background: Gene expression measurements from breast cancer (BrCa) tumors are established clinical p...